Sergio Luquero‐Bueno

Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

José Curbelo, Sergio Luquero‐Bueno, José María Galván‐Román et al. · PLoS ONE · 2017 · 164 citations · Full text

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

Macarena Hernández‐Jiménez, Samuel Martín‐Vílchez, Dolores Ochoa et al. · Molecular Therapy — Nucleic Acids · 2022 · 51 citations · Full text

Immunology, Pharmacotherapy, Immunotherapy +23

Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia

José María Galván‐Román, A. Lancho, Sergio Luquero‐Bueno et al. · PLoS ONE · 2020 · 27 citations · Full text

Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers

Miriam Saiz‐Rodríguez, Dolores Ochoa, Pablo Zubiaur et al. · Journal of Personalized Medicine · 2023 · 14 citations · Full text

Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers

Manuel Román Martinez, Eva García Aguilar, Samuel Martín Vílchez et al. · Drugs in R&D · 2022 · 12 citations · Full text